Akari Therapeutics, Plc
AKTX
$11.04
$0.080.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 183.81% | 7.20% | 100.19% | 10.60% | -35.10% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 19.02% | 16.59% | 101.09% | -11.87% | -44.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -31.47% | -35.71% | -71.65% | 22.83% | 52.13% |
| Total Current Assets | 152.17% | 7.17% | 85.03% | 7.75% | -34.97% |
|
|
|||||
| Total Current Assets | 152.17% | 7.17% | 85.03% | 7.75% | -34.97% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | 0.00% | -- | -- |
| Goodwill | -- | -- | 0.00% | -- | -- |
| Total Other Intangibles | -22.66% | -22.66% | -13.22% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -24.13% | -33.50% | -5.28% | 1,559.69% | 902.97% |
|
|
|||||
| Total Accounts Payable | -19.01% | -33.87% | -29.31% | 126.77% | 147.70% |
| Total Accrued Expenses | 42.34% | -4.75% | -25.34% | -37.70% | 46.47% |
| Short-term Debt | -55.20% | -60.35% | -76.87% | 111.70% | 54.70% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -78.36% | -71.44% | -56.15% | -5.48% | 7.67% |
| Total Other Current Liabilities | -78.36% | -71.44% | -56.15% | -5.48% | 7.67% |
| Total Current Liabilities | -18.69% | -35.83% | -37.97% | 65.13% | 95.22% |
|
|
|||||
| Total Current Liabilities | -18.69% | -35.83% | -37.97% | 65.13% | 95.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -55.20% | -60.35% | -76.87% | 111.70% | 54.70% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -25.39% | -26.63% | -14.37% | -- | -- |
| Total Liabilities | -20.85% | -33.22% | -30.95% | 140.66% | 188.26% |
|
|
|||||
| Common Stock & APIC | 7.21% | 6.11% | 7.47% | 24.46% | 22.61% |
| Retained Earnings | -12.24% | -11.18% | -7.00% | -6.48% | -5.10% |
| Treasury Stock & Other | 14.80% | 13.91% | 13.81% | -0.43% | -0.69% |
| Total Common Equity | -27.38% | -33.87% | 27.44% | 438.92% | 791.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.38% | -33.87% | 27.44% | 438.92% | 791.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.38% | -33.87% | 27.44% | 438.92% | 791.47% |
|
|
|||||